Why Blood Sugar Goes Up

  • Milind Watve


Readers are bound to wonder why in a book on diabetes we have not discussed blood sugar levels at sufficient length so far and why it is delayed till the 12th chapter. The common perception of diabetes begins with blood sugar and often ends with blood sugar. We saw in Chap. 3 that there are a series of paradoxes associated with the existing theory of glucose homeostasis and the conventionally perceived etiology of hyperglycemia. The alternative picture needs to resolve all the paradoxes. We can attempt to do so at this stage since by now I think sufficient background about the new interpretation has been built on which we can construct a new model of normal glucose regulation and altered glucose dynamics in T2D. Discussing sugar so late in this book also serves as a gesture intended to emphasize that sugar levels in blood are actually not as important in diabetes as generally believed. Raised blood sugar to diabetes is just what fever is to typhoid. It is only one of the many symptoms. However, it is one that is easiest to monitor and therefore the first indication in diagnosis and one that can also be conveniently used to follow the progression of the illness as well as any recovery from it. But that is its limitation. Just as fever is not everything in typhoid, blood sugar is not everything in T2D. Typhoid is an infection, and fever is only a symptom. If typhoid is cured, fever will certainly vanish, and the body temperature will return to normal. The reverse is not true. Fever can be reduced by antipyretic drugs or other physical means. Keeping the body on ice can also reduce the body temperature temporarily. But fever gone is not typhoid gone. The relation of blood sugar to T2D is very similar. Bringing blood sugar back to normal is not an indication of diabetes gone.


Sugar Obesity Depression Corticosteroid Respiration 


  1. 1.
    Schwartz MW, Porte D (2005) Diabetes, obesity, and the brain. Science 307:375–379PubMedGoogle Scholar
  2. 2.
    Prodi E, Obici S (2006) Minireview: the brain as a molecular target for diabetic therapy. Endocrinology 147:2664–2669PubMedGoogle Scholar
  3. 3.
    Cryer PE (1994) Banting lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 43:1378–1389PubMedGoogle Scholar
  4. 4.
    Mitrakou A et al (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260:67–74Google Scholar
  5. 5.
    Obici S, Zhang BB, Karkanias G, Rossetti L (2002) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8:1376–1382PubMedGoogle Scholar
  6. 6.
    Matsuhisa M et al (2000) Important role of the hepatic vagus nerve in glucose uptake and production by the liver. Metabolism 49:11–16PubMedGoogle Scholar
  7. 7.
    Xue C et al (2000) Isolated hepatic cholinergic denervation impairs glucose and glycogen metabolism. J Surg Res 90:19–25PubMedGoogle Scholar
  8. 8.
    Simpson IA et al (1999) Blood–brain barrier glucose transporter. J Neurochem 72:238–247PubMedGoogle Scholar
  9. 9.
    Yamaguchi N (1992) Sympathoadrenal system in neuroendocrine control of glucose: mechanisms involved in the liver, pancreas, and adrenal gland under hemorrhagic and hypoglycemic stress. Can J Physiol Pharmacol 70:167–206PubMedGoogle Scholar
  10. 10.
    Gilon P, Henquin J-C (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr Rev 22:565–604PubMedGoogle Scholar
  11. 11.
    Mitrani P, Srinivasan M, Dodds C, Patel MS (2007) Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the high-carbohydrate rat model. Am J Physiol Endocrinol Metab 292:1364–1377Google Scholar
  12. 12.
    Mitrani P, Srinivasan M, Dodds C, Patel MS (2007) Role of the autonomic nervous system in the development of hyperinsulinemia by high-carbohydrate formula feeding to neonatal rats. Am J Physiol Endocrinol Metab 292:1069–1078Google Scholar
  13. 13.
    Rossi J, Santamäki P, Airaksinen MS, Herzig K-H (2005) Parasympathetic innervation and function of endocrine pancreas requires the glial cell line-derived factor family receptor α2 (GFRα2). Diabetes 54:1324–1330PubMedGoogle Scholar
  14. 14.
    Cryer PE, Gerich JE (1985) Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med 313:232–241PubMedGoogle Scholar
  15. 15.
    Borg WP et al (1994) Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 93:1677–1682PubMedGoogle Scholar
  16. 16.
    Benton D, Parker PY, Donohoe RT (1996) The supply of glucose to the brain and cognitive functioning. J Biosoc Sci 28:463–479PubMedGoogle Scholar
  17. 17.
    Madsen PL, Cruz NF, Sokoloff L, Dienel GA (1999) Cerebral oxygen/glucose ratio is low during sensory stimulation and rises above normal during recovery[colon] excess glucose consumption during stimulation is not accounted for by lactate efflux from or accumulation in brain tissue. J Cereb Blood Flow Metab 19:393–400PubMedGoogle Scholar
  18. 18.
    Lund Madsen P et al (1995) Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the kety-schmidt technique. J Cereb Blood Flow Metab 15:485–491Google Scholar
  19. 19.
    Lu G, Hidenori K (2009) A mathematical model of brain glucose homeostasis. Theor Biol Med Model 6:26Google Scholar
  20. 20.
    Peters A et al (2004) The selfish brain: competition for energy resources. Neurosci Biobehav Rev 28:143–180PubMedGoogle Scholar
  21. 21.
    Langemann D (2007) Selfish-brain theory: challenges in the top-down analysis of metabolic supply chains. In: Grundy J, Hartmann S, Laender AHF, Maciaszek L, Roddick JF (eds) Proceedings of the tutorials, posters, panels and industrial contributions at the 26th international conference on conceptual modeling – ER 2007. Auckland, New Zealand, CRPIT, 83, pp. 39–49Google Scholar
  22. 22.
    Hitze B et al (2010) How the selfish brain organizes its supply and demand. Front Neuroenergetics 2:7PubMedGoogle Scholar
  23. 23.
    Peters A (2011) The selfish brain: competition for energy resources. Am J Hum Biol 23:29–34PubMedGoogle Scholar
  24. 24.
    Peters A, Langemann D (2009) Build-ups in the supply chain of the brain: on the neuroenergetic cause of obesity and type 2 diabetes mellitus. Front Neuroenergetics 1:1–15Google Scholar
  25. 25.
    Chung M, Göbel B (2012) Mathematical modeling of the human energy metabolism based on the selfish brain theory. Adv Exp Med Biol 736:425–440PubMedGoogle Scholar
  26. 26.
    van Dyken R et al (2010) Low plasma lactate concentration as a biomarker of an incompetent brain-pull: a risk factor for weight gain in type 2 diabetes patients. Psychoneuroendocrinology 35:1287–1293PubMedGoogle Scholar
  27. 27.
    Prentki M (2006) Islet cell failure in type 2 diabetes. J Clin Invest 116:1802–1812PubMedGoogle Scholar
  28. 28.
    D’Alessio DA, Kieffer TJ, Taborsky GJ, Havel PJ (2001) Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. J Clin Endocrinol Metab 86:1253–1259PubMedGoogle Scholar
  29. 29.
    Jarhult J, Holst J (1979) The role of the adrenergic innervation to the pancreatic islets in the control of insulin release during exercise in man. Pflugers Arch 383:41–45PubMedGoogle Scholar
  30. 30.
    N’Guyen JM et al (1994) Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic β cell in rats. J Clin Invest 94:1456–1462PubMedGoogle Scholar
  31. 31.
    Ahrén B et al (1997) Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6 J mice. Metabolism 46:97–106PubMedGoogle Scholar
  32. 32.
    Del Rio G et al (1997) Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Int J Obes Relat Metab Disord 21:1111–1114PubMedGoogle Scholar
  33. 33.
    Glasbrenner B, Dominguez-Munoz E, Riepl RL, Vetsi A, Malfertheiner P (1995) Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy. Dig Dis Sci 40:406–411PubMedGoogle Scholar
  34. 34.
    Buysschaert M, Donckier J, Dive A, Ketelslegers JM, Lambert AE (1985) Gastric acid and pancreatic polypeptide responses to sham feeding are impaired in diabetic subjects with autonomic neuropathy. Diabetes 34:1181–1185PubMedGoogle Scholar
  35. 35.
    Kurose T et al (1992) Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro. Diabetologia 35:1035–1041PubMedGoogle Scholar
  36. 36.
    Begin-Heick N (1994) Liver β-adrenergic receptors, G proteins, and adenylyl cyclase activity in obesity-diabetes syndromes. Am J Physiol 266:1664–1672Google Scholar
  37. 37.
    Koo S-H et al (2004) PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nat Med 10:530–534PubMedGoogle Scholar
  38. 38.
    Yoon JC et al (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131–138PubMedGoogle Scholar
  39. 39.
    Terada S et al (2002) Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun 296:350–354PubMedGoogle Scholar
  40. 40.
    Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829–839PubMedGoogle Scholar
  41. 41.
    Mootha VK et al (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267–273PubMedGoogle Scholar
  42. 42.
    Hammarstedt A, Jansson P-A, Wesslau C, Yang X, Smith U (2003) Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Commun 301:578–582PubMedGoogle Scholar
  43. 43.
    Crunkhorn S et al (2007) Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J Biol Chem 282:15439–15450PubMedGoogle Scholar
  44. 44.
    Liang H, Ward WF (2006) PGC-1α: a key regulator of energy metabolism. Adv Physiol Educ 30:145–151PubMedGoogle Scholar
  45. 45.
    Evans ML, Sherwin RS (2002) Brain glucose metabolism and hypoglycaemia. Diabetes Nutr Metab 15:294–296, discussion 296PubMedGoogle Scholar
  46. 46.
    Buettner C, Camacho RC (2008) Hypothalamic control of hepatic glucose production and its potential role in insulin resistance. Endocrinol Metab Clin North Am 37:825–840PubMedGoogle Scholar
  47. 47.
    German J et al (2009) Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 150:4502–4511PubMedGoogle Scholar
  48. 48.
    Rother E, Könner AC, Brüning JC (2008) Neurocircuits integrating hormone and nutrient signaling in control of glucose metabolism. Am J Physiol Endocrinol Metab 294:E810–E816PubMedGoogle Scholar
  49. 49.
    Obici S et al (2001) Central melanocortin receptors regulate insulin action. J Clin Invest 108:1079–1085PubMedGoogle Scholar
  50. 50.
    Könner AC et al (2007) Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab 5:438–449PubMedGoogle Scholar
  51. 51.
    Silver I, Erecinska M (1994) Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J Neurosci 14:5068–5076PubMedGoogle Scholar
  52. 52.
    Gjedde A, Rasmussen M (1980) Pentobarbital anesthesia reduces blood-brain glucose transfer in the rat. J Neurochem 35:1382–1387PubMedGoogle Scholar
  53. 53.
    Hargreaves RJ, Planas AM, Cremer JE, Cunningham VJ (1986) Studies on the relationship between cerebral glucose transport and phosphorylation using 2-deoxyglucose. J Cereb Blood Flow Metab 6:708–716PubMedGoogle Scholar
  54. 54.
    Cremer JE, Cunningham VJ, Seville MP (1983) Relationships between extraction and metabolism of glucose, blood flow, and tissue blood volume in regions of rat brain. J Cereb Blood Flow Metab 3:291–302PubMedGoogle Scholar
  55. 55.
    Lautt WW et al (2001) Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting. Am J Physiol Gastrointest Liver Physiol 281:G29–G36PubMedGoogle Scholar
  56. 56.
    Correia NC, Guarino MP, Raposo J, Macedo MP (2002) Hepatic guanylyl cyclase inhibition induces HISS-dependent insulin resistance. Proc West Pharmacol Soc 45:57–58PubMedGoogle Scholar
  57. 57.
    Pelligrino DA, LaManna JC, Duckrow RB, Bryan RM Jr, Harik SI (1992) Hyperglycemia and blood-brain barrier glucose transport. J Cereb Blood Flow Metab 12:887–899PubMedGoogle Scholar
  58. 58.
    McNay EC, McCarty RC, Gold PE (2001) Fluctuations in brain glucose concentration during behavioral testing: dissociations between brain areas and between brain and blood. Neurobiol Learn Mem 75:325–337PubMedGoogle Scholar
  59. 59.
    Herzog RI, Sherwin RS, Rothman DL (2011) Insulin-induced hypoglycemia and its effect on the brain. Diabetes 60:1856–1858PubMedGoogle Scholar
  60. 60.
    McCall AL, Millington WR, Wurtman RJ (1982) Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. Proc Natl Acad Sci U S A 79:5406–5410PubMedGoogle Scholar
  61. 61.
    Gjedde A, Crone C (1981) Blood-brain glucose transfer: repression in chronic hyperglycemia. Science 214:456–457PubMedGoogle Scholar
  62. 62.
    Matthaei S, Horuk R, Olefsky JM (1986) Blood-brain glucose transfer in diabetes mellitus. Decreased number of glucose transporters at blood-brain barrier. Diabetes 35:1181–1184PubMedGoogle Scholar
  63. 63.
    Pardridge WM, Triguero D, Farrell CR (1990) Downregulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes 39:1040–1044PubMedGoogle Scholar
  64. 64.
    Cornford EM, Hyman S, Cornford ME, Clare-Salzler M (1995) Down-regulation of blood-brain glucose transport in the hyperglycemic nonobese diabetic mouse. Neurochem Res 20:869–873PubMedGoogle Scholar
  65. 65.
    Kumagai AK (1999) Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes Metab Res Rev 15:261–273PubMedGoogle Scholar
  66. 66.
    Koranyi L et al (1991) Glucose transporter gene expression in rat brain: pretranslational changes associated with chronic insulin-induced hypoglycemia, fasting, and diabetes. Mol Cell Neurosci 2:244–252PubMedGoogle Scholar
  67. 67.
    Vorbrodt A, Dobrogowka D, Meeker H, Carp R, Tarnawski M (2007) Quantitative immunogold study of glucose transporter (GLUT-1) in five brain regions of scrapie-infected mice showing obesity and reduced glucose tolerance. Acta Neuropathol 102:278–284Google Scholar
  68. 68.
    Wertheimer E, Sasson S, Cerasi E, Ben-Neriah Y (1991) The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins. Proc Natl Acad Sci USA 88:2525–2529PubMedGoogle Scholar
  69. 69.
    Ehrlich JC, Ratner IM (1961) Amyloidosis of the islets of langerhans. Am J Pathol 38:49–59PubMedGoogle Scholar
  70. 70.
    Maloy AL, Longnecker DS, Robert Greenberg E (1981) The relation of islet amyloid to the clinical type of diabetes. Hum Pathol 12:917–922PubMedGoogle Scholar
  71. 71.
    Kahn SE, Andrikopoulos S, Verchere CB (1999) Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48:241–253PubMedGoogle Scholar
  72. 72.
    Hull RL, Westermark GT, Westermark P, Kahn SE (2004) Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89:3629–3643PubMedGoogle Scholar
  73. 73.
    Teff KL (2010) Cephalic phase pancreatic polypeptide responses to liquid and solid stimuli in humans. Physiol Behav 99:317–323PubMedGoogle Scholar
  74. 74.
    Berthoud HR, Bereiter DA, Trimble ER, Siegel EG, Jeanrenaud B (1981) Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization. Diabetologia 20:393–401PubMedGoogle Scholar
  75. 75.
    Mattes RD, Engelman K, Mattern J, Teff KL (1993) Cephalic-phase insulin in obese and normal-weight men: relation to postprandial insulin. Metabolism 42:1600–1608PubMedGoogle Scholar
  76. 76.
    Berthoud HR, Jeanrenaud B (1982) Sham feeding-induced cephalic phase insulin release in the rat. Am J Physiol Endocrinol Metab 242:280–285Google Scholar
  77. 77.
    Rohner-Jeanrenaud F, Jeanrenaud B (1983) The central nervous system-endocrine pancreas axis. Ann Endocrinol (Paris) 44:217–227Google Scholar
  78. 78.
    Calhoun P et al (1986) Evaluation of insulin secretion after pancreas autotransplantation by oral or intravenous glucose challenge. Ann Surg 204:585–593PubMedGoogle Scholar
  79. 79.
    Succurro E et al (2008) Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity 16:1881–1886PubMedGoogle Scholar
  80. 80.
    Spyer G, Hattersley AT, MacDonald I, Amiel S, MacLeod KM (2000) Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes. Lancet 356:1970–1974PubMedGoogle Scholar
  81. 81.
    DeFronzo RA, Hendler R, Christensen N (1980) Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration. Diabetes 29:125–131PubMedGoogle Scholar
  82. 82.
    Boyle PJ et al (1988) Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318:1487–1492PubMedGoogle Scholar
  83. 83.
    Bolli G et al (1983) Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Inter­action of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32:134–141PubMedGoogle Scholar
  84. 84.
    Simonson D, Tamborlane WWV, De Fronzo R, Sherwin RS (1985) Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Ann Intern Med 103:184–190PubMedGoogle Scholar
  85. 85.
    Palmer JP, Henry DP, Benson JW, Johnson DG, Ensinck JW (1976) Glucagon response to hypoglycemia in sympathectomized man. J Clin Invest 57:522–525PubMedGoogle Scholar
  86. 86.
    Popp DA, Shah SD, Cryer PE (1982) Role of epinephrine-mediated β-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. J Clin Invest 69:315–326PubMedGoogle Scholar
  87. 87.
    Monzillo LU, Hamdy O (2003) Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 61:397–412PubMedGoogle Scholar
  88. 88.
    Brun J-F, Raynaud E, Mercier J (2000) Homeostasis model assessment and related simplified evaluations of insulin sensitivity from fasting insulin and glucose. Diabetes Care 23:1037–1038PubMedGoogle Scholar
  89. 89.
    Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548PubMedGoogle Scholar
  90. 90.
    Avignon A, Boegner C, Mariano-Goulart D, Colette C, Monnier L (1999) Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes 23:512–517Google Scholar
  91. 91.
    Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedGoogle Scholar
  92. 92.
    Brüning JC et al (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559–569PubMedGoogle Scholar
  93. 93.
    DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMedGoogle Scholar
  94. 94.
    Kahn CR (2003) Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes. Exp Diabesity Res 4:169–182PubMedGoogle Scholar
  95. 95.
    Michael MD et al (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87–97PubMedGoogle Scholar
  96. 96.
    Campbell IW (1976) The somogyi phenomenon. A short review. Acta Diabetol Lat 13:68–73PubMedGoogle Scholar
  97. 97.
    Shanik MH et al (2008) Insulin resistance and hyperinsulinemia: Is hyperinsulinemia the cart or the horse? Diabetes Care 31:262–268Google Scholar
  98. 98.
    Ono T, Steffens AB, Sasaki K (1983) Influence of peripheral and intracerebroventricular glucose and insulin infusions on peripheral and cerebrospinal fluid glucose and insulin levels. Physiol Behav 30:301–306PubMedGoogle Scholar
  99. 99.
    Burdakov D, Luckman SM, Verkhratsky A (2005) Glucose-sensing neurons of the hypothalamus. Philos Trans R Soc Lond B Biol Sci 360:2227–2235PubMedGoogle Scholar
  100. 100.
    Levin BE, Dunn-Meynell AA, Routh VH (1999) Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am J Physiol 276:R1223–R1231PubMedGoogle Scholar
  101. 101.
    Clinkenbeard KD, Reed WD, Mooney RA, Lane MD (1975) Intracellular localization of the 3-hydroxy-3-methylglutaryl coenzyme A cycle enzymes in liver. Separate cytoplasmic and mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A generating systems for cholesterogenesis and ketogenesis. J Biol Chem 250:3108–3116PubMedGoogle Scholar
  102. 102.
    Williamson DH, Bates MW, Krebs HA (1968) Activity and intracellular distribution of enzymes of ketone-body metabolism in rat liver. Biochem J 108:353–361PubMedGoogle Scholar
  103. 103.
    Chapman MJ, Miller LR, Ontko JA (1973) Localization of the enzymes of ketogenesis in rat liver mitochondria. J Cell Biol 58:284–306PubMedGoogle Scholar
  104. 104.
    Laffel L (1999) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15:412–426PubMedGoogle Scholar
  105. 105.
    Kitabchi AE et al (2001) Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131–153PubMedGoogle Scholar
  106. 106.
    Bolli G et al (1979) Urinary excretion and plasma levels of norepinephrine and epinephrine during diabetic ketoacidosis. Acta Diabetol Lat 16:157–167PubMedGoogle Scholar
  107. 107.
    Porte D (1969) Sympathetic regulation of insulin secretion: its relation to diabetes mellitus. Arch Intern Med 123:252–260PubMedGoogle Scholar
  108. 108.
    Kreisberg RA (1978) Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment. Ann Intern Med 88:681–695PubMedGoogle Scholar
  109. 109.
    McRae JR et al (1985) Prostaglandin E2 metabolite levels during diabetic ketoacidosis. Diabetes 34:761–766PubMedGoogle Scholar
  110. 110.
    Johnson ME, Das NM, Butcher FR, Fain JN (1972) The regulation of gluconeogenesis in isolated rat liver cells by glucagon, insulin, dibutyryl cyclic adenosine monophosphate, and fatty acids. J Biol Chem 247:3229–3235PubMedGoogle Scholar
  111. 111.
    Rattigan S, Clark MG, Barrett EJ (1997) Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes 46:1381–1388PubMedGoogle Scholar
  112. 112.
    Laakso M, Edelman SV, Brechtel G, Baron AD (1992) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41:1076–1083PubMedGoogle Scholar
  113. 113.
    Laakso M, Edelman SV, Brechtel G, Baron AD (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85:1844–1852PubMedGoogle Scholar
  114. 114.
    Bingham EM et al (2002) The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 51:3384–3390PubMedGoogle Scholar
  115. 115.
    Donohoe RT, Benton D (1999) Cognitive functioning is susceptible to the level of blood glucose. Psychopharmacology 145:378–385PubMedGoogle Scholar
  116. 116.
    Benton D, Owens DS (1993) Blood glucose and human memory. Psychopharmacology 113:83–88PubMedGoogle Scholar
  117. 117.
    Martin PY, Benton D (1999) The influence of a glucose drink on a demanding working memory task. Physiol Behav 67:69–74PubMedGoogle Scholar
  118. 118.
    Benton D (1990) The impact of increasing blood glucose on psychological functioning. Biol Psychol 30:13–19PubMedGoogle Scholar
  119. 119.
    Donohoe RT, Benton D (2000) Glucose tolerance predicts performance on tests of memory and cognition. Physiol Behav 71:395–401PubMedGoogle Scholar
  120. 120.
    Nelson SR, Schulz DW, Passonneau JV, Lowry OH (1968) Control of glycogen levels in brain1. J Neurochem 15:1271–1279PubMedGoogle Scholar
  121. 121.
    Sickmann HM, Waagepetersen HS, Schousboe A, Benie AJ, Bouman SD (2010) Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis. J Cereb Blood Flow Metab 30:1527–1537PubMedGoogle Scholar
  122. 122.
    Heikkilä O et al (2010) Cerebellar glucose during fasting and acute hyperglycemia in nondiabetic men and in men with type 1 diabetes. Cerebellum 9:336–344PubMedGoogle Scholar
  123. 123.
    Rseaquist E, Tkac I, Damberg G, Thomas W, Gruetter R (2005) Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism 54:1008–1013Google Scholar
  124. 124.
    Heikkilä O et al (2010) Evidence for abnormal glucose uptake or metabolism in thalamus during acute hyperglycaemia in type 1 diabetes – a 1 H MRS study. Metab Brain Dis 25:227–234PubMedGoogle Scholar
  125. 125.
    Criego AB et al (2005) Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J Neurosci Res 79:42–47PubMedGoogle Scholar
  126. 126.
    Lei H, Gruetter R (2006) Effect of chronic hypoglycaemia on glucose concentration and glycogen content in rat brain: a localized 13  C NMR study. J Neurochem 99:260–268PubMedGoogle Scholar
  127. 127.
    Boyle PJ et al (1994) Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA 91:9352–9356PubMedGoogle Scholar
  128. 128.
    Káplár M et al (2009) Changes in cerebral blood flow detected by SPECT in type 1 and type 2 diabetic patients. J Nucl Med 50:1993–1998PubMedGoogle Scholar
  129. 129.
    Cosentino F et al (2009) Impact of fasting glycemia and regional cerebral perfusion in diabetic subjects: a study with technetium-99 m-ethyl cysteinate dimer single photon emission computed tomography. Stroke 40:306–308PubMedGoogle Scholar
  130. 130.
    Mårin P, Andersson B, Krotkiewski M, Björntorp P (1994) Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 17:382–386PubMedGoogle Scholar
  131. 131.
    Lillioja S et al (1987) Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80:415–424PubMedGoogle Scholar
  132. 132.
    Lash JM, Sherman WM, Hamlin RL (1989) Capillary basement membrane thickness and capillary density in sedentary and trained obese Zucker rats. Diabetes 38:854–860PubMedGoogle Scholar
  133. 133.
    Hattersley AT, Tooke JE (1999) The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 353:1789–1792PubMedGoogle Scholar
  134. 134.
    Šalković-Petrišić M, Riederer P (2010) Brain glucose transporter protein 2 and sporadic Alzheimer’s disease. Transl Neurosci 1:200–206Google Scholar
  135. 135.
    Wijesuriya HC, Bullock JY, Faull RLM, Hladky SB, Barrand MA (2010) ABC efflux transporters in brain vasculature of Alzheimer’s subjects. Brain Res 1358:228–238PubMedGoogle Scholar
  136. 136.
    Correia SC et al (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10:264–273PubMedGoogle Scholar
  137. 137.
    Klepper J, Voit T (2002) Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain – a review. Eur J Pediatr 161:295–304PubMedGoogle Scholar
  138. 138.
    Seidner G et al (1998) GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 18:188–191PubMedGoogle Scholar
  139. 139.
    Wang D et al (2006) A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet 15:1169–1179PubMedGoogle Scholar
  140. 140.
    Korytkowski MT et al (1998) Reduced β-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness. Diabetes Care 21:1939–1943PubMedGoogle Scholar
  141. 141.
    Cryer PE (1993) Hypoglycemia unawareness in IDDM. Diabetes Care 16(Suppl 3):40–47PubMedGoogle Scholar
  142. 142.
    Veneman TF, Erkelens DW (1997) Clinical review 88: hypoglycemia unawareness in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:1682–1684PubMedGoogle Scholar
  143. 143.
    Klepper J, Diefenbach S, Kohlschütter A, Voit T (2004) Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. Prostaglandins Leukot Essent Fatty Acids 70:321–327PubMedGoogle Scholar
  144. 144.
    Klepper J et al (2005) Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively. Neuropediatrics 36:302–308PubMedGoogle Scholar
  145. 145.
    Liu Z-H, Guan T-J, Chen Z-H, Li L-S (1999) Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int 55:1843–1848PubMedGoogle Scholar
  146. 146.
    Ng DPK et al (2002) Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. Diabetes 51:2264–2269PubMedGoogle Scholar
  147. 147.
    Pontiroli AE et al (1996) Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations. Acta Diabetol 33:193–197PubMedGoogle Scholar
  148. 148.
    Hodgkinson AD, Millward BA, Demaine AG (2001) Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy. Kidney Int 59:985–989PubMedGoogle Scholar
  149. 149.
    Baroni M et al (1992) Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM). Hum Genet 88:557–561PubMedGoogle Scholar
  150. 150.
    Um HS et al (2008) Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer’s disease in an NSE/APPsw-transgenic model. Int J Mol Med 22:529–539PubMedGoogle Scholar
  151. 151.
    Boyle PJ et al (1994) Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans. J Clin Invest 93:529–535PubMedGoogle Scholar
  152. 152.
    Maquet P et al (1990) Cerebral glucose utilization during sleep-wake cycle in man determined by positron emission tomography and [18 F]2-fluoro-2-deoxy-d-glucose method. Brain Res 513:136–143PubMedGoogle Scholar
  153. 153.
    Nofzinger EA et al (2002) Human regional cerebral glucose metabolism during non‐rapid eye movement sleep in relation to waking. Brain 125:1105–1115PubMedGoogle Scholar
  154. 154.
    Shah GN, Giddings SJ, Mooradian AD (1997) Shortening of poly (A) tail of glucose transporter – one mRNA in experimental diabetes mellitus. Brain Res 754:213–220PubMedGoogle Scholar
  155. 155.
    Pifferi F et al (2005) (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J Nutr 135:2241–2246PubMedGoogle Scholar
  156. 156.
    Pifferi F et al (2007) n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. Prostaglandins Leukot Essent Fatty Acids 77:279–286PubMedGoogle Scholar
  157. 157.
    Ximenes da Silva A et al (2002) Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J Neurochem 81:1328–1337PubMedGoogle Scholar
  158. 158.
    Freemantle E et al (2006) Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids 75:213–220PubMedGoogle Scholar
  159. 159.
    Liu D, Pitta M, Mattson MP (2008) Preventing NAD  +  depletion protects neurons against excitotoxicity. Ann N Y Acad Sci 1147:275–282PubMedGoogle Scholar
  160. 160.
    Mayman CI, Gatfield PD, Breckenridge BM (1964) The glucose content of brain in anaesthesia. J Neurochem 11:483–487PubMedGoogle Scholar
  161. 161.
    Duelli R, Kuschinsky W (2001) Brain glucose transporters: relationship to local energy demand. News Physiol Sci 16:71–76PubMedGoogle Scholar
  162. 162.
    McEwen BS, Reagan LP (2004) Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 490:13–24PubMedGoogle Scholar
  163. 163.
    Zeller K, Rahner-Welsch S, Kuschinsky W (1997) Distribution of Glut1 glucose transporters in different brain structures compared to glucose utilization and capillary density of adult rat brains. J Cereb Blood Flow Metab 17:204–209PubMedGoogle Scholar
  164. 164.
    Grolund KM et al (1996) Chronic seizures increase glucose transporter abundance in rat brain. J Neuro­pathol Exp Neurol 55:832–840Google Scholar
  165. 165.
    Burkhalter J, Fiumelli H, Allaman I, Chatton J-Y, Martin J-L (2003) Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons. J Neurosci 23:8212–8220PubMedGoogle Scholar
  166. 166.
    Sparrow B, Liu J, Wegner DM (2011) Google effects on memory: cognitive consequences of having information at our fingertips. Science 333:776–778PubMedGoogle Scholar
  167. 167.
    van de Ven KCC et al (2011) Effect of acute hypoglycemia on human cerebral glucose metabolism measured by 13  C magnetic resonance spectroscopy. Diabetes 60:1467–1473PubMedGoogle Scholar
  168. 168.
    Gruetter R et al (1992) Direct measurement of brain glucose concentrations in humans by 13  C NMR spectroscopy. Proc Natl Acad Sci USA 89:1109–1112PubMedGoogle Scholar
  169. 169.
    Oddo M et al (2008) Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 36:3233–3238PubMedGoogle Scholar
  170. 170.
    Kumagai AK, Kang YS, Boado RJ, Pardridge WM (1995) Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 44:1399–1404PubMedGoogle Scholar
  171. 171.
    McCall AL et al (1986) Chronic hypoglycemia increases brain glucose transport. Am J Physiol Endocrinol Metab 251:E442–E447Google Scholar
  172. 172.
    Sutherland GR et al (1999) A mobile high-field magnetic resonance system for neurosurgery. J Neurosurg 91:804–813PubMedGoogle Scholar
  173. 173.
    Bays HE (2004) Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obesity 12:1197–1211Google Scholar
  174. 174.
    Sandoval DA, Obici S, Seeley RJ (2009) Targeting the CNS to treat type 2 diabetes. Nat Rev Drug Discov 8:386–398PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Milind Watve
    • 1
  1. 1.Indian Institute of Science Education and Research Pune (IISER-P)PuneIndia

Personalised recommendations